Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Metastatic Castration-resistant Prostate Cancer 1Carcinoma, Renal Cell 1Carcinoma, Adenoid Cystic 1

Interventions

pembrolizumab 7lenvatinib 3apatinib 3Magnetic Resonance Spectroscopy 3Imatinib Mesylate 3Carboplatin 3gallium 68 PSMA-11 2Specimen Handling 2Protons 2Nivolumab 2Epirubicin 2Cisplatin 2Axitinib 24-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 23-(5-fluorobenzofuran-3-yl)-4-(5-methyl-5H-(1,3)dioxolo(4,5-f)indol-7-yl)-pyrrole-2,5-dione 2tislelizumab 1regorafenib 1enfortumab vedotin 1cabozantinib 1avelumab 1anlotinib 1amivantamab 1abemaciclib 1Tretinoin 1Trastuzumab 1Tablets 1Surveys and Questionnaires 1Surgical Procedures, Operative 1Sunitinib 1Standard of Care 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Adenoid Cystic × 177Lu-EB-PSMA-617 × Clear all
NCT04801264 2021-03-23

Diagnosis of Adenoid Cystic Carcinoma on 68Ga-PSMA-617 PET-CT and Therapy With 177Lu-EB-PSMA-617

Peking Union Medical College Hospital

Phase EARLY_PHASE1 Unknown
40 enrolled

Carcinoma, Adenoid Cystic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡